logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
17/09/2025
The international CEO of Lai Lai Company stated that the company will submit applications for the listing of the Oufu Glezin tablets in the United States, United Kingdom, European Union, Japan, and China in the coming weeks.
Latest
2 m ago
Trump pressured + Germany turned to Europe to expand freezing Russian assets to aid Ukraine.
3 m ago
Silicon Industry Branch: This week, the average transaction price of n-type polysilicon secondary materials increased by 8.57% compared to the previous week.
3 m ago
The Pacific issued a research report on September 17th, giving Burtelli (603596.SH) a buy rating. The main reasons for the rating include: 1) building a leading chassis "XYZ+ intelligent driving assistance" full series solution provider; 2) global production capacity layout + core components independently controllable. (Daily Economic News)
3 m ago
Nordic Nord Product and Investment Portfolio Strategy Manager Helge: Compared with competitors' weight loss drugs, semaglutide tablets have very attractive advantages.
3 m ago
Nord and Nord products and Investment Portfolio Strategy Manager Helgeot: Compared to competitors like Rilai's weight-loss pills, the Wegovy Pill has a very attractive advantage.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.